Attached files

file filename
8-K - OMEGA Q2 2011 EARNINGS RELEASE - OMEGA HEALTHCARE INVESTORS INCform_8k.htm

 


 
PRESS RELEASE – FOR IMMEDIATE RELEASE

OMEGA ANNOUNCES SECOND QUARTER 2011 FINANCIAL RESULTS;
ADJUSTED FFO OF $0.47 PER SHARE FOR THE SECOND QUARTER


HUNT VALLEY, MARYLAND – August 4, 2011 – Omega Healthcare Investors, Inc. (NYSE:OHI) (the “Company” or “Omega”) today announced its results of operations for the three- and six-month period ended June 30, 2011.  The Company also reported Funds From Operations (“FFO”) available to common stockholders for the three-month period ended June 30, 2011 of $42.6 million or $0.42 per common share.  The $42.6 million of FFO available to common stockholders for the second quarter of 2011 includes a $4.1 million provision for uncollectible accounts receivable, $1.5 million of non-cash stock-based compensation expense, $0.2 million net loss associated with the run-off of owned and operated assets and a $16 thousand adjustment in non-cash preferred stock redemption charges.  FFO is presented in accordance with the guidelines for the calculation and reporting of FFO issued by the National Association of Real Estate Investment Trusts (“NAREIT”).  Adjusted FFO was $0.47 per common share for the three-month period ended June 30, 2011.  FFO and Adjusted FFO are non-GAAP financial measures.  Adjusted FFO is calculated as FFO available to common stockholders excluding the impact of certain non-cash items and certain items of revenue or expense, including, but not limited to: results of operations of owned and operated facilities during the period, expenses associated with acquisitions, provisions for impairment and uncollectible accounts receivable and stock-based compensation expense.  For more information regarding FFO and Adjusted FFO, see the “Second Quarter 2011 Results – Funds From Operations” section below.

GAAP NET INCOME

For the three-month period ended June 30, 2011, the Company reported net income of $17.8 million and net income available to common stockholders of $17.8 million, or $0.17 per diluted common share on operating revenues of $72.6 million.  This compares to net income of $15.5 million and net income available to common stockholders of $13.2 million, or $0.14 per diluted common share on operating revenues of $58.8 million, for the same period in 2010.

For the six-month period ended June 30, 2011, the Company reported net income of $11.9 million and net income available to common stockholders of $6.7 million, or $0.07 per diluted common share on operating revenues of $143.1 million.  This compares to net income of $36.5 million and net income available to common stockholders of $31.9 million, or $0.35 per diluted common share on operating revenues of $117.5 million, for the same period in 2010.

The year-to-date decreases in both net income and net income available to common stockholders were primarily due to: (i) increased depreciation expense associated with over $640 million of new investments (including capital improvements) made throughout 2010 and 2011; (ii) impairment charges related to five real estate assets recorded in the first quarter of 2011; (iii) increased interest expense associated with debt instruments issued and assumed in 2010 primarily related to the asset acquisitions from CapitalSource Inc. (“CapitalSource”); (iv) provisions for uncollectible accounts receivable related to one of our operators; (v) increased general and administrative expenses resulting from new investments; and (vi) income associated with cash received from a legal settlement in the first quarter of 2010.  In addition to the aforementioned items, net income available to common stockholders was also reduced by a non-cash charge related to the redemption of the Company’s 8.375% Series D Cumulative Redeemable Preferred Stock in 2011.  This impact was partially offset by revenue associated with the new investments completed in 2010 and 2011.


 
 

 



SECOND QUARTER 2011 HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

·  
In July 2011, the Company increased its quarterly common dividend per share to $0.40 from $0.38.
·  
In July 2011, the Company completed an exchange offer for $575 million of its 6¾% senior notes due 2022 issued on October 4, 2010 and November 23, 2010 in two separate private placements.
·  
In April 2011, the Company increased its quarterly common dividend per share to $0.38 from $0.37.

SECOND QUARTER 2011 RESULTS

Operating Revenues and Expenses – Operating revenues for the three-month period ended June 30, 2011 were $72.6 million.  Operating expenses for the three-month period ended June 30, 2011, excluding nursing home expenses for owned and operated assets, totaled $33.8 million and were comprised of $24.8 million of depreciation and amortization expense, a $4.1 million provision for uncollectible accounts receivable, $3.4 million of general and administrative expense and $1.5 million of stock-based compensation expense.  A reconciliation of these amounts to revenues and expenses reported in accordance with GAAP is provided at the end of this release.

Other Income and Expense – Other income and expense for the three-month period ended June 30, 2011 was a net expense of $20.8 million, which was comprised of $20.1 million of interest expense and $0.7 million of amortized deferred financing costs.

Funds From Operations – For the three-month period ended June 30, 2011, reportable FFO available to common stockholders was $42.6 million, or $0.42 per common share on 102 million weighted-average common shares outstanding, compared to $29.7 million, or $0.32 per common share on 93 million weighted-average common shares outstanding, for the same period in 2010.

The $42.6 million of FFO for the three-month period ended June 30, 2011 includes the impact of approximately $4.1 million of provisions for uncollectible accounts receivable, $1.5 million of non-cash stock-based compensation expense, a $0.2 million net loss associated with owned and operated assets and $16 thousand of preferred stock redemption charges.

The $29.7 million of FFO for the second quarter of 2010 includes the impact of: (i) a charge of approximately $3.5 million relating to the write-off of deferred financing costs associated with the termination of the Company’s 2009 credit facility; (ii) $1.2 million of costs associated with the CapitalSource asset acquisitions; (iii) $0.5 million of non-cash restricted stock expense; (iv) a $0.2 million real estate impairment charge; (v) $0.2 million of net income associated with owned and operated assets; and (vi) a $0.8 million gain on the sales of two mortgage backed securities that were bought in the first quarter of 2010 and sold in the second quarter of 2010.

Adjusted FFO was $92.8 million, or $0.92 per common share, for the six-month period ended June 30, 2011, compared to $67.5 million, or $0.74 per common share, for the same period in 2010.  The Company had 8.8 million additional weighted-average shares for the six months ended June 30, 2011 compared to the same period in 2010.  The increase in weighted-average common shares was primarily a result of: (i) approximately 4.5 million common shares issued under the equity shelf programs and (ii) approximately 3.4 million common shares issued under the Company’s Dividend Reinvestment and Common Stock Purchase Plan.  For further information see “Funds From Operations” below.


FINANCING ACTIVITIES
 
$575 Million 6¾% Senior Notes Exchange On July 14, 2011, the Company exchanged $575 million of its 6¾% Senior Notes due 2022 (the “2022 Notes”) that had been registered under the Securities Act of 1933 for $575 million of its outstanding 6¾% Senior Notes due 2022.  The 2022 Notes were sold in October and November 2010 in two separate private placements.  The October 2010 private placement was sold at an issue price of 98.984% of the $225 million principal amount resulting in gross proceeds to the Company of approximately $223 million.  The November 2010 private placement was sold at an issue price of 103% of the $350 million principal amount resulting in gross proceeds to the Company of approximately $361 million.
 
Equity Shelf Program and the Dividend Reinvestment and Direct Stock Purchase Plan During the six-month period ended June 30, 2011, the Company sold the following shares of its common stock:

Equity Shelf (At-The-Market) Program for 2011
 
(in thousands, except price per share)
 
                   
      Q1       Q2    
Year
 
   
Total
   
Total
   
To Date
 
                       
Number of shares                                    
    1,261       158       1,419  
Average price per share
  $ 22.78     $ 21.27     $ 22.61  
Net proceeds                                    
  $ 28,145     $ 3,306     $ 31,451  
                         
Dividend Reinvestment and Direct Stock Purchase Program for 2011
 
(in thousands, except price per share)
 
      Q1       Q2    
Year
 
   
Total
   
Total
   
To Date
 
                         
Number of shares                                     
    795       1,093       1,888  
Average price per share
  $ 22.08     $ 21.17     $ 21.55  
Net proceeds                                     
  $ 17,555     $ 23,136     $ 40,691  


PORTFOLIO AND RECENT DEVELOPMENTS

Connecticut Facilities – In January 2011, upon the Company’s request, a complaint was filed by the State of Connecticut, Commissioner of Social Services (the “State”), against the licensees/operators of the Company’s four Connecticut skilled nursing facilities (“SNFs”), seeking the appointment of a receiver.  The SNFs were leased and operated by FC/SCH and were managed by Genesis.  The Superior Court, Judicial District of Hartford, Connecticut appointed a receiver.

The receiver is responsible for (i) operating the facilities and funding all operational expenses incurred after the appointment of the receiver and (ii) providing the court with recommendations regarding the facilities.  In March, the receiver moved to close all four SNFs and the Company objected.  At the hearing held on April 21, 2011, the Company stated its position that the receiver failed to comply with the statutory requirements prior to recommending the facilities’ closure.  In addition, alternative operators expressed interest in operating several of the facilities.  On April 27, 2011, the Court granted the receiver’s motion and ordered the facilities closed.

The Company timely filed its notice of appeal, taking the position that the Court's Order (the “Order”) is final and appealable, and erroneous.  Following the Company’s notice of appeal, the Company negotiated a stipulation with the State and the receiver which afforded it significant concessions.  Those concessions included: (a) an agreed recognition of the Company as a secured lienholder with a priority claim, (b) an accelerated time frame for the (i) allocation by the Receiver of collected funds between pre- and post- receivership periods, and (ii) disbursement to the Company of pre-receivership funds collected, and (c) an agreement by the State that it would forego its right to seek recoupment of pre-receivership funds as reimbursement for post-receivership advances.  In exchange for these concessions (among others), the Company withdrew its appeal.

As a result of the Court’s Order, the Company recorded an impairment charge of $24.4 million during the three-month period ended March 31, 2011, in accordance with US Generally Accepted Accounting Principles, to reduce the carrying values of the Connecticut facilities to their fair values.  While this impairment charge reduced first quarter and year-to-date net income, the closure of the facilities does not impact the Company’s adjusted FFO guidance, which is discussed below.

FC/SCH Facilities – On June 15, 2011, the Company executed an Agreement To Enter Into Master Lease And Restructure Certain Obligations (“MTA”) with Genesis Healthcare, LLC (“Genesis”) and FC/SCH Partners, LLC and FC Properties WV, LLC (previously referred to as “Formation” and hereafter “FC/SCH”) related to the eleven facilities currently leased by FC/SCH.  Among other things, the MTA provides at the closing:

1.  
a subsidiary of Genesis will enter into a new long-term master lease providing for a twelve-year initial term;
2.  
Genesis will deliver a guaranty of the new master lease;
3.  
the restructuring of certain indebtedness of FC/SCH to Omega, including, the guaranty of Genesis to repay such indebtedness as restructured; and
4.  
the release of certain other obligations of FC/SCH.

The sole condition to the closing of the transactions contemplated by the MTA is the receipt of all necessary healthcare regulatory approvals in Massachusetts, New Hampshire, Rhode Island and West Virginia to the transfer of the operating licenses from FC/SCH to Genesis.  If not received as of the closing, the facilities located in Vermont will be added to the new master lease when the regulatory approvals for Vermont are received.

As a result of the MTA, during the second quarter of 2011, the Company evaluated the recoverability of the straight-line rent and lease inducements associated with FC/SCH and recorded a $4.1 million provision for uncollectible accounts associated with straight-line receivables and lease inducements.


DIVIDENDS

Common Dividends – On July 14, 2011, the Company’s Board of Directors announced a common stock dividend of $0.40 per share, increasing the quarterly common dividend by $0.02, or 5.3%, per share over the prior quarter, to be paid August 15, 2011 to common stockholders of record on August 1, 2011.  At the date of this release, the Company had approximately 103 million common shares outstanding.


 
2011 ADJUSTED FFO GUIDANCE
 

The Company modified its guidance for 2011 Adjusted FFO available to common stockholders to be between $1.82 and $1.86 per diluted share.  In January 2011, the Company issued its guidance indicating 2011 Adjusted FFO available to common stockholders would be between $1.80 and $1.86 per diluted share.

The Company’s Adjusted FFO guidance for 2011 excludes the impact of gains and losses from the sale of assets, additional divestitures, impairment of assets, certain revenue and expense items, capital transactions and restricted stock amortization expense.  A reconciliation of the Adjusted FFO guidance to the Company’s projected GAAP earnings is provided on a schedule attached to this press release.  The Company may, from time to time, update its publicly announced Adjusted FFO guidance, but it is not obligated to do so.

The Company’s Adjusted FFO guidance is based on a number of assumptions, which are subject to change and many of which are outside the control of the Company.  If actual results vary from these assumptions, the Company's expectations may change.  Without limiting the generality of the foregoing, the completion of acquisitions, divestitures, capital and financing transactions, and variations in restricted stock amortization expense may cause actual results to vary materially from our current expectations.  There can be no assurance that the Company will achieve its projected results.


CONFERENCE CALL

The Company will be conducting a conference call on Thursday, August 4, 2011, at 10 a.m. Eastern to review the Company’s 2011 second quarter results and current developments.  Analysts and investors interested in participating are invited to call (877) 317-6789 from within the United States or (412) 317-6789 from outside the United States and ask the operator to be connected to the “Omega Healthcare Second Quarter 2011 Earnings Call.”

To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the “earnings call” icon on the Company’s home page.  Webcast replays of the call will be available on the Company’s website for two weeks following the call.

*   *   *   *   *   *

The Company is a real estate investment trust investing in and providing financing to the long-term care industry.  At June 30, 2011, the Company owned or held mortgages on 398 skilled nursing facilities, assisted living facilities and other specialty hospitals with approximately 46,126 licensed beds (44,376 available beds) located in 35 states and operated by 50 third-party healthcare operating companies.  In addition, the Company has two facilities currently held for sale.

FOR FURTHER INFORMATION, CONTACT
Bob Stephenson, CFO at (410) 427-1700
________________________

 
This announcement includes forward-looking statements, including without limitation the information under the heading “2011 Adjusted FFO Guidance Confirmed.”  Actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of the Company’s properties, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels; (ii) regulatory and other changes in the healthcare sector; (iii) changes in the financial position of the Company’s operators; (iv) the ability of any of the Company’s operators in bankruptcy to reject unexpired lease obligations, modify the terms of the Company’s mortgages and impede the ability of the Company to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations; (v) the availability and cost of capital; (vi) changes in the Company’s credit ratings and the ratings of its debt securities; (vii) competition in the financing of healthcare facilities; (viii) the Company’s ability to maintain its status as a real estate investment trust; (ix) the Company’s ability to manage, re-lease  or sell any owned and operated facilities; (x) the Company’s ability to sell closed or foreclosed assets on a timely basis and on terms that allow the Company to realize the carrying value of these assets; (xi) the effect of economic and market conditions generally, and particularly in the healthcare industry; and (xii) other factors identified in the Company’s filings with the Securities and Exchange Commission. Statements regarding future events and developments and the Company’s future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.  The Company undertakes no obligation to update any forward-looking statements contained in this announcement.
 

 
 

 


OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
   
June 30,
   
December 31,
 
   
2011
   
2010
 
   
(Unaudited)
       
ASSETS
           
Real estate properties
           
Land and buildings
  $ 2,339,689     $ 2,366,856  
Less accumulated depreciation
    (420,651 )     (380,995 )
Real estate properties – net
    1,919,038       1,985,861  
Mortgage notes receivable – net
    113,202       108,557  
      2,032,240       2,094,418  
Other investments – net
    29,278       28,735  
      2,061,518       2,123,153  
Assets held for sale – net
    811       670  
Total investments
    2,062,329       2,123,823  
                 
Cash and cash equivalents
    4,996       6,921  
Restricted cash
    20,609       22,399  
Accounts receivable – net
    94,315       92,819  
Other assets
    58,455       57,172  
Operating assets for owned and operated properties
    275       873  
Total assets
  $ 2,240,979     $ 2,304,007  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Revolving line of credit
  $ 53,000     $  
Secured borrowings
    199,454       201,296  
Unsecured borrowings – net
    975,477       975,669  
Accrued expenses and other liabilities
    110,487       121,859  
Operating liabilities for owned and operated properties
    472       1,117  
Total liabilities
    1,338,890       1,299,941  
                 
Stockholders’ equity:
               
Preferred stock issued and outstanding – 4,340 shares Series D with an aggregate liquidation preference of $108,488 as of December 31, 2010
              108,488  
Common stock $.10 par value authorized – 200,000 shares issued and outstanding – 102,624 shares as of June 30, 2011 and 99,233 as of December 31, 2010
      10,262         9,923  
Common stock – additional paid-in-capital
    1,452,935       1,376,131  
Cumulative net earnings
    592,701       580,824  
Cumulative dividends paid
    (1,153,809 )     (1,071,300 )
Total stockholders’ equity
    902,089       1,004,066  
Total liabilities and stockholders’ equity
  $ 2,240,979     $ 2,304,007  






 
 

 

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)

   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Revenue
                       
Rental income
  $ 68,487     $ 51,520     $ 134,824     $ 98,729  
Mortgage interest income
    3,433       2,519       6,931       5,133  
Other investment income – net
    617       1,790       1,258       2,536  
Miscellaneous
    69       20       69       3,749  
Nursing home revenues of owned and operated assets
    -       2,956       -       7,336  
Total operating revenues
    72,606       58,805       143,082       117,483  
                                 
Expenses
                               
Depreciation and amortization
    24,759       16,451       49,977       31,138  
General and administrative
    3,411       3,205       7,158       6,076  
Stock-based compensation expense
    1,519       467       2,998       1,306  
Acquisition costs
    -       1,192       45       1,412  
Impairment on real estate properties
    -       155       24,971       155  
Provisions for uncollectible mortgages, notes and accounts receivable
    4,139       -       4,139       -  
Nursing home expenses of owned and operated assets
    225       2,797       455       7,369  
Total operating expenses
    34,053       24,267       89,743       47,456  
                                 
Income before other income and expense
    38,553       34,538       53,339       70,027  
Other income (expense):
                               
Interest income
    12       62       23       77  
Interest expense
    (20,072 )     (14,705 )     (40,072 )     (28,280 )
Interest – amortization of deferred financing costs
    (703 )     (925 )     (1,397 )     (1,903 )
Interest –refinancing costs
    -       (3,461 )     (16 )     (3,461 )
Total other expense
    (20,763 )     (19,029 )     (41,462 )     (33,567 )
                                 
Net income
    17,790       15,509       11,877       36,460  
Preferred stock dividends
    -       (2,272 )     (1,691 )     (4,543 )
Preferred stock redemption
    16       -       (3,456 )     -  
Net income available to common
  $ 17,806     $ 13,237     $ 6,730     $ 31,917  
                                 
Income per common share available to common shareholders:
                               
Basic:
                               
Net income
  $ 0.17     $ 0.14     $ 0.07     $ 0.35  
Diluted:
                               
Net income
  $ 0.17     $ 0.14     $ 0.07     $ 0.35  
                                 
Dividends declared and paid per common share
  $ 0.38     $ 0.32     $ 0.75     $ 0.64  
                                 
Weighted-average shares outstanding, basic
    101,912       93,031       100,993       90,935  
Weighted-average shares outstanding, diluted
    102,001       93,153       101,044       91,057  
                                 
Components of other comprehensive income:
                               
Net income
  $ 17,790     $ 15,509     $ 11,877     $ 36,460  
Unrealized loss on other investments
    -       (38 )     -       -  
Total comprehensive income
  $ 17,790     $ 15,471     $ 11,877     $ 36,460  




 
 

 


OMEGA HEALTHCARE INVESTORS, INC.
FUNDS FROM OPERATIONS
Unaudited
(in thousands, except per share amounts)

   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Net income available to common stockholders
  $ 17,806     $ 13,237     $ 6,730     $ 31,917  
Elimination of non-cash items included in net income:
                               
Depreciation and amortization
    24,759       16,451       49,977       31,138  
Funds from operations available to common stockholders
  $ 42,565     $ 29,688     $ 56,707     $ 63,055  
                                 
Weighted-average common shares outstanding, basic
    101,912       93,031       100,993       90,935  
Restricted stock PRUs
    77       114       39       112  
Assumed exercise of stock options
                      5  
Deferred stock
    12       8       12       5  
Weighted-average common shares outstanding, diluted
    102,001       93,153       101,044       91,057  
                                 
Funds from operations per share available to common stockholders
  $ 0.42     $ 0.32     $ 0.56     $ 0.69  
                                 
Adjusted funds from operations:
                               
Funds from operations available to common stockholders
  $ 42,565     $ 29,688     $ 56,707     $ 63,055  
Deduct litigation settlements
                      (1,111 )
Deduct gain from sale of securities
          (789 )           (789 )
Deduct nursing home revenues
          (2,956 )           (7,336 )
Deduct/add back non-cash preferred stock redemption charges
    (16 )           3,456        
Add back non-cash provision for impairments on real estate properties
          155       24,971       155  
Add back non-cash provision for uncollectible accounts receivable
    4,139             4,139        
Add back nursing home expenses
    225       2,797       455       7,369  
Add back interest refinancing expense
          3,461       16       3,461  
Add back acquisition costs
          1,192       45       1,412  
Add back non-cash stock-based compensation expense
    1,519       467       2,998       1,306  
Adjusted funds from operations available to common stockholders
  $ 48,432     $ 34,015     $ 92,787     $ 67,522  

This press release includes Funds From Operations, or FFO, which is a non-GAAP financial measure.  For purposes of the Securities and Exchange Commission’s Regulation G, a non-GAAP financial measure is a numerical measure of a company’s historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable financial measure calculated and presented in accordance with GAAP in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the company, or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable financial measure so calculated and presented.  As used in this press release, GAAP refers to generally accepted accounting principles in the United States of America.  Pursuant to the requirements of Regulation G, the Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

The Company calculates and reports FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts ("NAREIT"), and consequently, FFO is defined as net income available to common stockholders, adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization.  The Company believes that FFO is an important supplemental measure of its operating performance.  Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions.  The term FFO was designed by the real estate industry to address this issue.  FFO described herein is not necessarily comparable to FFO of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from the Company.

The Company uses FFO as one of several criteria to measure the operating performance of its business.  The Company further believes that by excluding the effect of depreciation, amortization and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO can facilitate comparisons of operating performance between periods and between other REITs.  The Company offers this measure to assist the users of its financial statements in analyzing its performance; however, this is not a measure of financial performance under GAAP and should not be considered a measure of liquidity, an alternative to net income or an indicator of any other performance measure determined in accordance with GAAP.  Investors and potential investors in the Company’s securities should not rely on this measure as a substitute for any GAAP measure, including net income.

Adjusted FFO is calculated as FFO available to common stockholders excluding the impact of non-cash stock-based compensation and certain revenue and expense items identified above.  The Company believes that Adjusted FFO provides an enhanced measure of the operating performance of the Company’s core portfolio as a REIT.  The Company’s computation of Adjusted FFO is not comparable to the NAREIT definition of FFO or to similar measures reported by other REITs, but the Company believes it is an appropriate measure for this Company.

 
 

 

The Company currently expects its 2011 Adjusted FFO available to common stockholders to be between $1.82 and $1.86 per diluted share.  The following table presents a reconciliation of our guidance regarding 2011 FFO and Adjusted FFO to net income available to common stockholders:

   
2011 Projected AFFO
 
Per diluted share:
                 
Net income available to common stockholders
  $ 0.47           $ 0.48  
Adjustments:
                       
Depreciation and amortization
    0.98             1.01  
Funds from operations available to common stockholders
  $ 1.45           $ 1.49  
                         
Adjustments:
                       
Preferred stock redemption charge
    0.03             0.03  
Provision for impairments on real estate properties
    0.24               0.24  
Provision for uncollectible accounts receivable
    0.04               0.04  
Stock-based compensation expense
    0.06             0.06  
Adjusted funds from operations available to common stockholders
  $ 1.82           $ 1.86  


The table below reconciles reported revenues and expenses to revenues and expenses excluding nursing home revenues and expenses of owned and operated assets:

   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
   
(in thousands)
 
Total operating revenues
  $ 72,606     $ 58,805     $ 143,082     $ 117,483  
Nursing home revenues of owned and operated assets
          2,956             7,336  
Revenues excluding nursing home revenues of owned and operated assets
  $ 72,606     $ 55,849     $ 143,082     $ 110,147  
                                 
Total operating expenses
  $ 34,053     $ 24,267     $ 89,743     $ 47,456  
Nursing home expenses of owned and operated assets
    225       2,797       455       7,369  
Expenses excluding nursing home expenses of owned and operated assets
  $ 33,828     $ 21,470     $ 89,288     $ 40,087  

This press release includes references to revenues and expenses excluding nursing home owned and operated assets, which are non-GAAP financial measures.  The Company believes that the presentation of the Company’s revenues and expenses, excluding nursing home owned and operated assets, provides a useful measure of the operating performance of the Company’s core portfolio as a real estate investment trust in view of the disposition of all but two of the Company’s owned and operated assets and short term holding of owned and operated assets.  Effective June 1, 2010, the Company no longer operates any facilities; therefore the revenues and expenses of these two entities are not included in our consolidated statements of operations after that effective date.

 
 

 


The following tables present selected portfolio information, including operator and geographic concentrations, and revenue maturities for the period ended June 30, 2011:
 
   
As of June 30, 2011
       
Balance Sheet Data
 
# of Properties
   
# of Operating Beds
   
Investment($000's)
   
% Investment
       
Real Property(1)
    385       42,821     $ 2,358,889       95 %      
Loans Receivable(2)
    13       1,555       113,202       5 %      
Total Investments
    398       44,376     $ 2,472,091       100 %      
   
Investment Data
 
# of Properties
   
# of Operating Beds
   
Investment($000's)
   
% Investment
   
Investment per Bed
 
Skilled Nursing Facilities (1) (2)
    383       43,573     $ 2,405,081       98 %   $ 55  
Assisted Living Facilities
    10       510       33,540       1 %     66  
Specialty Hospitals and Other
    5       293       33,470       1 %     114  
      398       44,376     $ 2,472,091       100 %   $ 56  
                                         
Note: table above excludes two facilities classified as held-for-sale.
(1) Includes $19.2 million for lease inducement.
(2) Includes $0.7 million of unamortized principal.
 
   

Revenue Composition ($000's)
                       
                         
Revenue by Investment Type
 
Three Months Ended
   
Six Months Ended
 
   
June 30, 2011
   
June 30, 2011
 
Rental Property (1)
  $ 68,487       94 %   $ 134,824       94 %
Mortgage Notes
    3,433       5 %     6,931       5 %
Other Investment Income
    617       1 %     1,258       1 %
    $ 72,537       100 %   $ 143,013       100 %
                                 
Revenue by Facility Type
 
Three Months Ended
   
Six Months Ended
 
   
June 30, 2011
   
June 30, 2011
 
Skilled Nursing Facilities (1)
  $ 70,286       96 %   $ 138,494       96 %
Assisted Living Facilities
    531       1 %     1,063       1 %
Specialty Hospitals
    1,103       2 %     2,198       2 %
Other
    617       1 %     1,258       1 %
    $ 72,537       100 %   $ 143,013       100 %
                                 
(1) 2nd quarter revenue includes $0.9 million reduction for lease inducement, and $1.9 million YTD. Excludes revenue from owned and operated assets.
 


Operator Concentration  by Investment ($000's)
                 
   
As of June 30, 2011
 
   
# of Properties
   
Investment
   
% Investment
 
CommuniCare Health Services
    36     $ 323,219       13 %
Airamid
    38       263,560       11 %
Sun Healthcare Group, Inc.
    40       228,769       9 %
Signature Holdings, LLC
    32       223,786       9 %
Gulf Coast
    17       146,636       6 %
Guardian LTC Management (1)
    23       145,171       6 %
Advocat Inc.
    36       144,818       6 %
LaVie
    17       117,654       5 %
Formation Capital
    12       110,559       4 %
Nexion
    20       86,733       3 %
Remaining 40 Operators (2)
    127       681,186       28 %
      398     $ 2,472,091       100 %
                         
Note: table above excludes two facilities classified as held-for-sale.
(1) Investment amount includes a $19.2 million lease inducement.
(2) Includes $0.7 million of unamortized principal.
 


 Concentration by State     # of Properties        Investment        % Investment   
Florida (1)
    86     $ 597,429       24 %
Ohio
    50       357,305       14 %
Pennsylvania
    25       174,051       7 %
Texas
    31       161,573       7 %
Tennessee
    16       115,017       5 %
Maryland
    10       98,738       4 %
West Virginia (2)
    10       79,719       3 %
Colorado
    11       71,666       3 %
Indiana
    18       69,670       3 %
Kentucky
    15       64,141       3 %
North Carolina
    11       59,602       2 %
Alabama
    11       59,179       2 %
Massachusetts
    8       57,049       2 %
Louisiana
    14       55,343       2 %
Mississippi
    6       52,417       2 %
Arkansas
    12       47,313       2 %
Remaining 19 States
    64       351,879       15 %
      398     $ 2,472,091       100 %
Note: table above excludes two facilities classified as held-for-sale.
(1) Includes $0.7 million of unamortized principal.
(2) Investment amount includes a $19.2 million lease inducement.
 


Revenue Maturities ($000's)
                         
 
As of June 30, 2011
 
Operating Lease Expirations & Loan Maturities
Year
 
Current Lease Revenue (1)
   
Current Interest Revenue (1)
   
Lease and Interest Revenue
   
%
 
 
2011
    1,202       -       1,202       1 %
 
2012
    3,992       -       3,992       2 %
 
2013
    33,318       -       33,318       13 %
 
2014
    2,005       691       2,696       1 %
 
2015
    2,051       -       2,051       1 %
                                   
                                   
(1) Based on 2011 contractual rents and interest (assumes no annual escalators).
 




 Operator Revenue Mix   % Revenue Mix
   
Medicaid
   
Medicare / Insurance
   
Private / Other
 
                   
Three-months ended March 31, 2011
    50 %     41.6 %     8.4 %


Operator Census and Coverage
       
Coverage Data
 
   
Census (1)
   
Before
Management Fees
   
After
Management Fees
 
                   
Twelve-months ended March 31, 2011
    84.2 %     2.2 x     1.8 x
Twelve-months ended December 31, 2010
    84.1 %     2.1 x     1.7 x
Twelve-months ended September 30, 2010
    84.0 %     2.0 x     1.6 x
Twelve-months ended June 30, 2010
    83.8 %     2.0 x     1.6 x
                         

(1)  
Based on available beds.

 

 
 

 

The following table presents a debt maturity schedule as of June 30, 2011:


Debt Maturities ($000's)     Secured Debt   Unsecured Debt        
 Year     Line of Credit (1)     HUD Mortgages (2)     Senior Notes     Sub Notes     Total Debt  
  2011     $ -     $ -     $ -     $ -     $ -  
  2012       -       -       -       -       -  
  2013       -       -       -       -       -  
  2014       320,000       -       -       -       320,000  
  2015       -       -       -       -       -  
  Thereafter       -       179,675       950,000       20,000       1,149,675  
      $ 320,000     $ 179,675     $ 950,000     $ 20,000     $ 1,469,675  
                                           
 (1) Reflcted at 100% borrowing capacity.
(2) Excluded $21.1 million of fair market valuations.
                                       


The following table presents investment activity for the three- and six - month period ended June 30, 2011:

                         
Investment Activity ($000's)
                       
   
Three Months Ended
   
Six Months Ended
 
   
June 30, 2011
   
June 30, 2011
 
Funding by Investment Type:
 
$ Amount
   
%
   
$ Amount
   
%
 
                         
Real Property
  $ -       - %   $ -       - %
Mortgages
    -       - %     -       - %
Other
    3,145       100 %     7,470       100 %
Total
  $ 3,145       100 %   $ 7,470       100 %